Precipio Inc. (NASDAQ: PRPO) shares surged 140% Monday after the company successfully launched its COVID-19 rapid antibody test that tests for both IgG & IgM antibodies. Testing for antibodies will let people know if they have previously been exposed to the virus or have been vaccinated.
Precipio holds the exclusive right to distribute the product on Amazon Inc.'s (NASDAQ: AMZN) platform.
Precipio Daily Chart Analysis
- Precipio looks to have broken out of what technical traders may call a falling wedge pattern.
- The stock crossed above both the 50-day moving average (green) as well as the 200-day moving average (blue) Monday. This indicates the sentiment of the stock …